Slowing the progression of chronic renal insufficiency

Tonelli, Marcello; Gill, John; Pandeya, Sanjaya; Bohm, Clara; Levin, Adeera; Kiberd, Bryce A.
April 2002
CMAJ: Canadian Medical Association Journal;4/2/2002, Vol. 166 Issue 7, p906
Academic Journal
Discusses a study of patients with chronic renal insufficiency (CRI) in Canada to investigate the use of strategies which delay or prevent progression of the disease. Strategies which include aggressive control of blood pressure and use of angiotensin-converting enzyme (ACE) inhibitors; Suggestion that angiotensin receptor blockers may have renal benefits; Evidence that patients with advanced CRI may benefit from these agents.


Related Articles

  • SYMPATHETIC NERVOUS SYSTEM ACTIVITY IN CHRONIC KIDNEY DISEASE. Sharma, M.; Bhowmik, D.; Deepak, K. K.; Tiwari, S. C.; Dash, S. C. // Indian Journal of Nephrology;Jul-Sep2007, Vol. 17 Issue 3, p107 

    Introduction: Hypertension is common in chronic kidney disease and plays a pivotal role in progression of renal dysfunction. The pathogenesis of hypertension in CKD is multifactorial. The stage at which the sympathetic activity starts to rise is still unclear. Hence this study was conducted to...

  • Research brief: ACE-inhibitors help advanced renal failure.  // GP: General Practitioner;1/20/2006, p7 

    The article cites a study which states that patients with advanced renal failure may benefit from treatment with an ACE inhibitor. In a trial of 224 patients with advanced renal failure, treatment with the ACE inhibitor benazepril was found to reduce the risk of severe renal disease, raised...

  • Blood pressure and progression of renal failure in the elderly. Acone, Daria; Cante, D0menico; Cillo, Francesca; Giordano, Gelsomina; Giordano, Carmelo // Kidney International;Jun1996 Supplement, Vol. 49, pS75 

    There are a lack of studies about elderly patients with chronic renal failure (CRF). We studied 22 patients, aged 64 to 74 years, who were diagnosed with hypertensive nephropathy (HN), defined as a diastolic blood pressure (DBP) < 95 mm Hg and a basal creatinine clearance (CCr) of 52 ± 6...

  • Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria. Viberti, Giancarlo; Chaturvedi, Nish // Kidney International Supplement;Dec1997, Issue 63, pS32 

    In adult diabetic patients microalbuminuria is a marker of early vascular damage in the micro- and macrocirculation. Microalbuminuria is a powerful predictor of renal and cardiovascular disease outcome and is associated with other, potentially modifiable, risk factors of vascular damage. Studies...

  • Review: the renoprotective effects of ACE inhibitors and ARBs independent of blood pressure control are uncertain. Casas, J. P.; Chua, W.; Loukogeorgakis, S. // Evidence Based Medicine;Oct2006, Vol. 11 Issue 5, p145 

    The article presents a study conducted in Great Britain which showed that there are no certain renoprotective effects for angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) independent to blood pressure control. Some of the factors considered in the study...

  • No impact of hyperkalaemia with renin–angiotensin system blockades in maintenance haemodialysis patients. Sang-Woong Han; Young-Woong Won; Joo-Hark Yi; Ho-Jung Kim // Nephrology Dialysis Transplantation;Apr2007, Vol. 22 Issue 4, p1150 

    Background. Renin–angiotensin system (RAS) blockades, angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are well accepted for the cardiorenal-protective benefits added to antihypertensive effects in chronic kidney diseases (CKD), but associated...

  • Angiotensin-Converting Enzyme Inhibition and Chronic Kidney Disease: Does Proteinuria Matter? Joshi, Amit J.; Levine, Jerrold S. // Kidney;Sep/Oct2007, Vol. 16 Issue 5, p204 

    The article discusses the mechanisms by which proteinuria may induce renal injury and the potential of angiotensin-converting enzyme inhibitors (ACEIs) to delay the progression of chronic kidney disease (CKD) in the U.S. It is shown that interventions that reduce proteinuria delay CKD...

  • Acute phosphate nephropathy. Markowitz, Glen S.; Perazella, Mark A. // Kidney International;Nov2009, Vol. 76 Issue 10, p1027 

    Acute phosphate nephropathy (APhN) is a clinical pathological entity characterized by acute and subsequent chronic renal failure following exposure to oral sodium phosphate (OSP) bowel purgatives. Renal biopsy findings include acute and chronic tubular injury with prominent tubular and...

  • Proteinuria predicting outcome in renal disease: Nondiabetic nephropathies (REIN). Remuzzi, Giuseppe; Chiurchiu, Carlos; Ruggenenti, Piero // Kidney International Supplement;Nov2004, Issue 92, pS90 

    Proteinuria predicting outcome in renal disease: Nondiabetic nephropathies (REIN). About two thirds of patients on renal replacement therapy irreversibly lose their kidney function because of progressive nephropathies, such as diabetic nephropathy and nondiabetic chronic renal disease. Halting...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics